Herpes zoster subunit vaccine
Jump to navigation
Jump to search
Dosage
- two doses were given 2 months apart
Mechanism of action
- contains varicella zoster virus glycoprotein E plus an adjuvant
Notes
- high efficacy in older adults[1]
- 97% efficacy, with similar benefits across age groups[1]
- cost effective in older adults[2]
More general terms
References
- ↑ 1.0 1.1 1.2 Lal H et al Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. N Engl J Med. April 28, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25916341 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1501184
- ↑ 2.0 2.1 Le P, Rothberg, MB Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. JAMA Intern Med. Published online January 2, 2018. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29297049 https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2666789
Najafzadeh M. Evolution of Herpes Zoster Vaccines and Their Economic Value. JAMA Intern Med. Published online January 2, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29297047 https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2666787